IGM Biosciences Inc (IGMS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

325 E MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043

IGM Biosciences, Inc. operates as a biotechnology company. The Company specializes in the research and development for the treatment of cancer. IGM Biosciences serves customers in the United States.

View SEC Filings from IGMS instead.

View recent insider trading info

Funds Holding IGMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IGMS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

20 Thousand total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LOBERG MICHAEL D

  • Director
0 2020-01-16 3

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,712,652 2019-12-31 1

BEHRENS M KATHLEEN

  • Director
82,500 2019-12-09 4

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
696,378 2019-10-29 1

TOPSOE JAKOB HALDOR

  • Director
  • 10% Owner
10,343,868 2019-09-24 6

HAMBLETON JULIE

  • Director
5,000 2019-09-18 3

HALDOR TOPSOE HOLDING A/S

  • 10% Owner
10,289,453 2019-09-18 2

TOPSOE CHRISTINA TENG

  • Director
  • 10% Owner
10,323,828 2019-09-18 4

NEU KELVIN

  • Director
0 2019-09-17 1

LEE MICHAEL STEWART

  • Director
0 2019-09-17 2

TAHIR MISBAH CHIEF FINANCIAL OFFICER

  • Officer
0 2019-09-17 1

STROHL WILLIAM

  • Director
0 2019-09-17 2

SCHWARZER FRED CEO AND PRESIDENT

  • Officer
  • Director
196,718 2019-09-17 1

KEYT BRUCE CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-09-17 1

CHEN DANIEL SHINYU CHIEF MEDICAL OFFICER

  • Officer
116,518 2019-09-17 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BEHRENS M KATHLEEN - Director see footnote

2019-12-09 P 5,497 $24.26 a 5,497 82,500.00 indirect

BEHRENS M KATHLEEN - Director see footnote

2019-12-09 P 5,497 $24.26 a 5,497 82,500.00 indirect

BEHRENS M KATHLEEN - Director see footnote

2019-12-09 P 4,503 $25.61 a 10,000 82,500.00 indirect

BEHRENS M KATHLEEN - Director see footnote

2019-12-09 P 4,503 $25.61 a 10,000 82,500.00 indirect
Click here to report any possible errors with this stock listing.

Elevate your investments